New drug combo trial offers hope for advanced stomach cancer patients
Disease control
Not yet recruiting
This study is testing whether a new drug called LBL-024, when combined with other cancer drugs, can help control advanced stomach or gastroesophageal junction cancer. The trial will enroll about 110 adults whose cancer has spread and cannot be surgically removed. Researchers will…
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC